NCT05071872View on ClinicalTrials.gov

PMCF of Rotarex®S & Aspirex®S Catheters in Treating Thrombotic Occlusion of Arteriovenous Graft

CompletedOBSERVATIONAL
Enrollment

127

Participants

Timeline

Start Date

October 6, 2021

Primary Completion Date

June 8, 2022

Study Completion Date

June 8, 2022

Conditions
Arteriovenous Graft Thrombosis
Interventions
DEVICE

Atherectomy/Thrombectomy

Percutaneous transluminal removal of thrombotic occlusion in arteriovenous graft

Trial Locations (1)

Unknown

Angiocentrum Příbram, Příbram

All Listed Sponsors
lead

Straub Medical AG

INDUSTRY

NCT05071872 - PMCF of Rotarex®S & Aspirex®S Catheters in Treating Thrombotic Occlusion of Arteriovenous Graft | Biotech Hunter | Biotech Hunter